Fig 1.
STARD flow diagram of study population.
Fig 2.
Details of a thyroid lesion diagnosed as positive for malignancy favoring papillary thyroid carcinoma on LBC, in the upper left a detail of nuclear inclusion (PAPx400).
Table 1.
Clinicopathologic features of 85 thyroid lesions with BN and PM diagnoses and histological follow-up.
Table 2.
CD56, HBME-1 and Galectin-3 staining score in the 85 BN and PM diagnoses with histological follow-up.
Positive and negative expression for each antibody among the cases.
Fig 3.
a) Details of CD56 negativity in the same case of Fig 1 (avidin-biotin-peroxidase complex x400); b) Details of negative CD56 expression on the histological sample for the same case (avidin-biotin-peroxidase complex x300).
Fig 4.
Details of cytoplasm-membranous CD56 positivity in a benign lesion diagnosed as BN (avidin-biotin-peroxidase complex x400);
b) Details of diffuse cytoplasm and membrane CD56 expression on the histological sample for the same case (avidin-biotin-peroxidase complex x300).
Table 3.
Descriptive statistics for each immunocytochemical marker in the cyto-histological series.
Table 4.
Concordant staining score for CD56, HBME-1 and Galectin-3 double and triple ICC combinations with histological follow-up§.
Table 5.
Descriptive statistics for immunocytochemical markers used in double and triple combinations in the concordant cyto-histological series§.